Search research articles
Contact Us
Filters
Showing results (1-10 of 326) with videos related to
Page
of 33
Sort By:
Oncology (Williston Park, N.Y.)
|
October 30, 2019
Mutations and the Importance of Genetic Testing
Allison W Kurian
Current Opinion in Obstetrics & Gynecology
|
October 21, 2009
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Allison W Kurian
Current Breast Cancer Reports
|
April 28, 2012
Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease
Shaveta Vinayak, Allison W Kurian
Current Treatment Options in Oncology
|
April 26, 2017
The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition
Anosheh Afghahi, Allison W Kurian
JAMA Oncology
|
November 2, 2018
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply
Allison W Kurian, Steven J Katz
JAMA Oncology
|
July 17, 2015
Multigene Panel Testing in Oncology Practice: How Should We Respond?
Allison W Kurian, James M Ford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control
Allison W Kurian, Steven J Katz
Journal of Oncology Practice
|
August 15, 2013
Information technology interventions to improve cancer care quality: a report from the American Society of Clinical Oncology Quality Care Symposium
Allison W Kurian, Stephen B Edge
JAMA Oncology
|
August 28, 2015
Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact
Allison W Kurian, Christopher R Friese
Journal of Medical Genetics
|
September 1, 2023
Recurrent <i>BRCA2</i> exon 3 deletion in Assyrian families
Rachel Hodan, Kerry Kingham, Allison W Kurian
Page
of 33
Search research articles
Search
Showing results (1-10 of 326) with videos related to
Sort By:
Page
of 33
Oncology (Williston Park, N.Y.)
|
October 30, 2019
Mutations and the Importance of Genetic Testing
Allison W Kurian
Current Opinion in Obstetrics & Gynecology
|
October 21, 2009
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Allison W Kurian
Current Breast Cancer Reports
|
April 28, 2012
Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease
Shaveta Vinayak, Allison W Kurian
Current Treatment Options in Oncology
|
April 26, 2017
The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition
Anosheh Afghahi, Allison W Kurian
JAMA Oncology
|
November 2, 2018
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply
Allison W Kurian, Steven J Katz
JAMA Oncology
|
July 17, 2015
Multigene Panel Testing in Oncology Practice: How Should We Respond?
Allison W Kurian, James M Ford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control
Allison W Kurian, Steven J Katz
Journal of Oncology Practice
|
August 15, 2013
Information technology interventions to improve cancer care quality: a report from the American Society of Clinical Oncology Quality Care Symposium
Allison W Kurian, Stephen B Edge
JAMA Oncology
|
August 28, 2015
Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact
Allison W Kurian, Christopher R Friese
Journal of Medical Genetics
|
September 1, 2023
Recurrent <i>BRCA2</i> exon 3 deletion in Assyrian families
Rachel Hodan, Kerry Kingham, Allison W Kurian
Page
of 33